You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

First patient enrolled in Modus’ sevuparin trial

Modus Therapeutics (Modus) – a company developing treatments for patients with high unmet medical needs – has announced the inclusion of the first patient in its SEVUSMART trial.